TESTOSTERONE GEL, 1%

TESTOSTERONE GEL, 1% was reported 255 times

These side effects are most commonly reported by patients taking TESTOSTERONE GEL, 1%:

# Side effect Count
0 NO ADVERSE EVENT 155
1 DEVICE DELIVERY SYSTEM ISSUE 108
2 DRUG DOSE OMISSION BY DEVICE 65
3 INCORRECT DOSE ADMINISTERED BY DEVICE 42
4 DRUG INEFFECTIVE 24
5 PRODUCT SUBSTITUTION ISSUE 21
6 PRODUCT QUALITY ISSUE 16
7 DEVICE MALFUNCTION 15
8 PRODUCT PACKAGING QUANTITY ISSUE 13
9 BLOOD TESTOSTERONE DECREASED 12
10 PRODUCT DOSE OMISSION ISSUE 11
11 INCORRECT DOSE ADMINISTERED 10
12 FATIGUE 9
13 PRODUCT USE ISSUE 9
14 RASH 7
15 DEVICE DEFECTIVE 6
16 OFF LABEL USE 6
17 PRODUCT ODOUR ABNORMAL 6
18 DEVICE BREAKAGE 5
19 HEADACHE 5
20 POOR QUALITY PRODUCT ADMINISTERED 5
21 PRODUCT PHYSICAL CONSISTENCY ISSUE 5
22 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5
23 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5
24 ARTHRALGIA 4
25 ASTHENIA 4
26 DEVICE ISSUE 4
27 PRODUCT PHYSICAL ISSUE 4
28 PRODUCT USE IN UNAPPROVED INDICATION 4
29 ACCIDENTAL EXPOSURE TO PRODUCT 3
30 DEVICE INEFFECTIVE 3
31 DIZZINESS 3
32 DRUG DELIVERY SYSTEM MALFUNCTION 3
33 EXPIRED PRODUCT ADMINISTERED 3
34 HEART RATE INCREASED 3
35 INCORRECT DOSE ADMINISTERED BY PRODUCT 3
36 LIBIDO DECREASED 3
37 POLYCYTHAEMIA 3
38 PRODUCT STORAGE ERROR 3
39 PRURITUS 3
40 ABDOMINAL PAIN 2
41 ACNE 2
42 ANXIETY 2
43 BACK PAIN 2
44 BLOOD TESTOSTERONE INCREASED 2
45 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2
46 DEPRESSION 2
47 DERMAL ABSORPTION IMPAIRED 2
48 DEVICE LEAKAGE 2
49 DISCOMFORT 2
50 DISORIENTATION 2
51 DISTURBANCE IN SEXUAL AROUSAL 2
52 DRUG DELIVERY SYSTEM ISSUE 2
53 DRY SKIN 2
54 DYSPEPSIA 2
55 DYSPNOEA 2
56 INTENTIONAL PRODUCT USE ISSUE 2
57 LOSS OF LIBIDO 2
58 NAUSEA 2
59 PALPITATIONS 2
60 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2
61 PRODUCT CONTAMINATION PHYSICAL 2
62 PRODUCT DISPENSING ERROR 2
63 SPEECH DISORDER 2
64 URTICARIA 2
65 VOMITING 2
66 ABDOMINAL DISCOMFORT 1
67 ABDOMINAL DISTENSION 1
68 ADRENAL INSUFFICIENCY 1
69 ADVERSE DRUG REACTION 1
70 ADVERSE EVENT 1
71 AFFECT LABILITY 1
72 AGITATION 1
73 ALOPECIA 1
74 ALPHA 1 FOETOPROTEIN INCREASED 1
75 ANAPHYLACTIC REACTION 1
76 ANGER 1
77 APHAGIA 1
78 APHONIA 1
79 APPLICATION SITE ACNE 1
80 APPLICATION SITE DERMATITIS 1
81 APPLICATION SITE ERYTHEMA 1
82 APPLICATION SITE ODOUR 1
83 APPLICATION SITE RASH 1
84 ARTHRITIS 1
85 ARTHROPOD INFESTATION 1
86 ATRIAL FIBRILLATION 1
87 BACK DISORDER 1
88 BALANCE DISORDER 1
89 BLOOD PRESSURE INCREASED 1
90 BLOOD TEST ABNORMAL 1
91 BRAIN FOG 1
92 BURNING SENSATION 1
93 CHEST DISCOMFORT 1
94 CHEST PAIN 1
95 CHILLS 1
96 CHROMATURIA 1
97 COGNITIVE DISORDER 1
98 CONFUSIONAL STATE 1
99 COORDINATION ABNORMAL 1
100 DEPRESSED MOOD 1
101 DEVICE DIFFICULT TO USE 1
102 DEVICE MECHANICAL ISSUE 1
103 DIARRHOEA 1
104 DRUG EFFECT LESS THAN EXPECTED 1
105 DRUG LEVEL BELOW THERAPEUTIC 1
106 DRUG RESISTANCE 1
107 DYSGEUSIA 1
108 ENLARGED CLITORIS 1
109 EXTRA DOSE ADMINISTERED 1
110 EYE SWELLING 1
111 FALL 1
112 FORMICATION 1
113 FRUSTRATION TOLERANCE DECREASED 1
114 GAIT INABILITY 1
115 GASTROINTESTINAL MOTILITY DISORDER 1
116 GENERAL PHYSICAL CONDITION ABNORMAL 1
117 GYNAECOMASTIA 1
118 HAEMATOCRIT ABNORMAL 1
119 HYPERCOAGULATION 1
120 HYPERHIDROSIS 1
121 HYPERSENSITIVITY 1
122 HYPERTENSION 1
123 HYPOGONADISM 1
124 IDIOPATHIC INTRACRANIAL HYPERTENSION 1
125 ILLNESS 1
126 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
127 INCORRECT PRODUCT ADMINISTRATION DURATION 1
128 INSOMNIA 1
129 IRRITABILITY 1
130 JOINT STIFFNESS 1
131 JOINT SWELLING 1
132 LABORATORY TEST ABNORMAL 1
133 LARYNGITIS 1
134 LETHARGY 1
135 LIQUID PRODUCT PHYSICAL ISSUE 1
136 LOCAL SWELLING 1
137 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
138 MALABSORPTION FROM ADMINISTRATION SITE 1
139 MALAISE 1
140 MANUFACTURING PROCESS CONTROL PROCEDURE ISSUE 1
141 MENTAL DISORDER 1
142 MENTAL IMPAIRMENT 1
143 MENTAL STATUS CHANGES 1
144 MIDDLE INSOMNIA 1
145 MOOD ALTERED 1
146 MUSCLE SPASMS 1
147 MUSCULAR WEAKNESS 1
148 MYALGIA 1
149 NASAL DRYNESS 1
150 NECK PAIN 1
151 NEURALGIA 1
152 OEDEMA PERIPHERAL 1
153 ORGANIC ERECTILE DYSFUNCTION 1
154 OROPHARYNGEAL PAIN 1
155 OVERDOSE 1
156 PAIN 1
157 PAIN IN EXTREMITY 1
158 PANIC ATTACK 1
159 PITUITARY TUMOUR 1
160 PORTAL VEIN THROMBOSIS 1
161 PRECOCIOUS PUBERTY 1
162 PRODUCT AVAILABILITY ISSUE 1
163 PRODUCT CONTAINER ISSUE 1
164 PRODUCT DELIVERY MECHANISM ISSUE 1
165 PRODUCT DESIGN ISSUE 1
166 PRODUCT DISPENSING ISSUE 1
167 PRODUCT EXPIRATION DATE ISSUE 1
168 PRODUCT LABEL CONFUSION 1
169 PRODUCT LOT NUMBER ISSUE 1
170 PRODUCT PREPARATION ERROR 1
171 PRODUCT PRESCRIBING ERROR 1
172 PRODUCT USE COMPLAINT 1
173 PRODUCT WITH QUALITY ISSUE ADMINISTERED 1
174 PRODUCTIVE COUGH 1
175 PSORIASIS 1
176 PULMONARY THROMBOSIS 1
177 RASH MACULAR 1
178 RASH PRURITIC 1
179 REACTION TO EXCIPIENT 1
180 SCAB 1
181 SINUS TACHYCARDIA 1
182 SKIN IRRITATION 1
183 SKIN REACTION 1
184 SLEEP DEFICIT 1
185 SOMNOLENCE 1
186 SUSPECTED PRODUCT QUALITY ISSUE 1
187 TASTE DISORDER 1
188 TESTICULAR PAIN 1
189 THERAPEUTIC PRODUCT EFFECT DELAYED 1
190 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
191 THERAPEUTIC PRODUCT INEFFECTIVE 1
192 THERAPEUTIC RESPONSE CHANGED 1
193 THERAPEUTIC RESPONSE UNEXPECTED 1
194 THERAPY CESSATION 1
195 THERAPY CHANGE 1
196 THROAT TIGHTNESS 1
197 TREMOR 1
198 VIRILISM 1
199 WEIGHT DECREASED 1
200 WEIGHT INCREASED 1